微粒载体控释投递抗原与佐剂的应用进展
    
    作者:任建敏,王缚鲲,邹全明,彭承琳
    Author:
    收稿日期:          年卷(期)页码:2001,(04):-295-296
    期刊名称:华西药学杂志
    Journal Name:WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
    关键字:微粒载体;抗原;佐剂;综述
    Key words:
    基金项目:
    中文摘要
    本文综述了近年来 ,微粒载体控释投递抗原在佐剂中的应用
    参考文献
    
- 1 DavisSS ,IllumL .Polymericmicrospheresasdrugcarriers[J ].Bioma terial,1988Jan,9(1):111 
- 2 EldridgeJH ,StaasJK ,MeulbroekJA ,etal.Biodegradablemicro spheresasavaccinesystem[J].MolecularImmunol,1991,28:287 
- 3 VogelFR ,powellMF .Chapter7.acompendiumofvaccineadjuvantsandexcipients.In:Vaccinedesign:thesubunitandadjuvantapproach[M].NewYork:PlenumPress,PowellMFed,1995.141 
- 4 O’HaganDT .JefferyH ,DavisSS .Long termantibodyresponsesinmicefollowingsubcutaneousimmunizationwithovalbuminentrappedinbiodegradablemicroparticles[J].Vaccine,1993,11(9):965 
- 5 SpierRE .Reportofameetimgonvaccines:newtechnologiesandap plications[J].VaccineAug,1995,13(11):1038 
- 6 HeathAW ,PlayfairJHL .Cytokinesasimmunologicaladjuants[J].Vac cine,1992,10(7):427 
- 7 WhalenRL ,DempseyDJ ,ThompsonLM ,etal.Microencapsulatedvac cinestoprovideprolongedimmunitywithasingleadministration[J]A SAIOJ ,1996,42(5):649 
- 8 MenYk,ThomasinC ,MerkleHP ,etal.AsingleadministrationoftetanustoxiodinbiodegradablemicrosphereselicitsTcellandantibodyrespousessinitarorsuperiortothoseoltainedwithaluminumhydroxide[J].Vaccine,1995,Mag,13(7):683 
- 9 ClelandJL ,BarronL ,daughertyA ,etal,Developmentofasingle shotsubunitvaccineforHIV 1.3.EeffectofadjuvantandimmunizationscheduleonthedurationofthehumoralimmuneresponsetorecombinantMNgp120[J].J pharm sci,1996,85(12):1350 
- 10 BarasB ,BenoitMA ,DupreL ,etal.Single dosemucosalimmuniza tionwithbiodegradablemicroparticlescontainingaschistosomamansoniantigen[J].InfectImmun,1999,67(5):2643 
- 11 NakaokaR ,TabataY ,IkadaY Potentialityofgelatinmicrosphereasimmunologicaladjuvant[J].Vaccine,1995May,13(7):653 
- 12 ParantMA ,AudibertFM ,ChedidLA ,etalImmunostimulantactivitiesofalipophilicmuramyldipeptidederivativeandofdesmuramylpepti dolipidanalogs[J].InfectImmun,1980Mar,27(3):826 
- 13 PayneLG ,JenkinsSA ,AndrianovA ,etalInVaccinedesign:Thesubunitandadjuvantapproach[M ]PowellMF ,NewmanMJ ,Eds.Plenum:NewYork,1995473 
- 14 TabataY ,IkadaY Macrophageactivationthroughphagocytosisofmu ramyldipeptideencapsulatedingelatinmicrospheres[J]JPharmPhar macol,1987,39(9):698 
- 15 AlvingCR ,VermaJN ,RaoM ,etal,LiposomescontaininglipidAasapotentnon toxicadjuvant[J]ResImmunol,1992,143(2):197 
- 16 ZhouF ,HuangL MonophosphoryllipidAenhancesspecificCTLin ductionbyasolubleproteinantigenentrappedinliposomes[J]Vac cine,1993,11(11):1139 
- 17 GluckR ,MischlerR ,BrantschenS ,JustM ,etalImmunopo tentiatingreconstitutedinfluenzavirusvirosomevaccinedeliverysystemforimmunizationagainsthepatitisA[J].JClinInvest,1992,90(6):2491 
- 18 SencerSF ,RichML ,KatsanisE ,etalAndersonPM Anti tumorvac cineadjuvanteffectsofIL 2liposomesinmiceimmunizedagainstMCA 102sarcoma[J].EurCytokineNetw,1991,2(5):311 
- 19 MaurerJ,MullerF ,VoglTJ,etalCurrentstatusofmagneticreso nancetomographyindiagnosisoftheanklejoint acriticalevaluation[J]AktuelleRadiol,1994,4(3):115 
 【关闭】